We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleClinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome.AuthorsSilk, D B A; Davis, A; Vulevic, J; Tzortzis, G; Gibson, G RAbstractGut microflora-mucosal interactions may be involved in the pathogenesis of irritable bowel syndrome (IBS).PublicationAlimentary pharmacology & therapeutics, 2009, Vol 29, Issue 5, p508ISSN1365-2036Publication typeJournal ArticleDOI10.1111/j.1365-2036.2008.03911.x